Globus Medical Q3 Adj $0.57, Inline, Sales $383.64M Miss $435.17M Estimate
Portfolio Pulse from Benzinga Newsdesk
Globus Medical (NYSE:GMED) reported Q3 earnings of $0.57 per share, meeting analyst consensus. This is a 14% increase from last year. However, the company's quarterly sales of $383.64M missed the analyst consensus estimate of $435.17M by 11.84%. Sales increased by 50.95% compared to the same period last year.
November 07, 2023 | 9:40 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Globus Medical's Q3 earnings met expectations, but sales missed estimates by 11.84%. This could potentially impact the company's stock price.
While Globus Medical's Q3 earnings met analyst expectations, the company's sales fell short of estimates. This mixed financial performance could lead to uncertainty among investors, potentially driving the stock price down in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100